• 1. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 2. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
• 3. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Aminopiperidines

Professional Introduction to N-methylpiperidin-3-amine (CAS No. 150395-92-9)

N-methylpiperidin-3-amine, a compound with the chemical identifier CAS No. 150395-92-9, is a significant molecule in the realm of pharmaceutical chemistry and drug development. This piperidine derivative has garnered attention due to its versatile applications in synthesizing bioactive molecules and its potential role in medicinal chemistry. The compound's unique structural features make it a valuable intermediate in the creation of various pharmacological agents, particularly those targeting neurological and cardiovascular systems.

The chemical structure of N-methylpiperidin-3-amine consists of a six-membered heterocyclic ring containing nitrogen, substituted with a methyl group at the 1-position and an amine group at the 3-position. This configuration imparts specific electronic and steric properties that are highly desirable in drug design. The presence of the amine group allows for further functionalization, enabling the synthesis of more complex molecules with tailored biological activities.

In recent years, there has been a surge in research focusing on piperidine derivatives due to their demonstrated efficacy in modulating various biological pathways. N-methylpiperidin-3-amine has been explored as a key building block in the development of novel therapeutic agents. Its role in synthesizing small-molecule drugs has been particularly noteworthy, with several studies highlighting its utility in creating compounds that exhibit potent activity against diseases such as Alzheimer's and Parkinson's.

One of the most compelling aspects of N-methylpiperidin-3-amine is its ability to serve as a precursor for molecules that interact with central nervous system (CNS) targets. The piperidine scaffold is known for its ability to cross the blood-brain barrier, making it an ideal candidate for developing neuropharmacological agents. Researchers have leveraged this property to create innovative drugs that address neurological disorders by modulating neurotransmitter systems.

Recent advancements in computational chemistry have further enhanced the understanding of how N-methylpiperidin-3-amine functions in drug design. Molecular modeling studies have revealed insights into its interactions with biological targets, providing a foundation for rational drug design. These studies have identified key structural features that contribute to its binding affinity and selectivity, guiding the development of more effective therapeutic agents.

The pharmaceutical industry has shown particular interest in N-methylpiperidin-3-amine due to its potential in creating next-generation drugs. Its incorporation into lead compounds has led to several promising candidates entering clinical trials. These trials have demonstrated the compound's ability to produce desired pharmacological effects while maintaining a favorable safety profile. The results have been instrumental in advancing our understanding of how piperidine derivatives can be utilized in treating complex diseases.

Beyond its applications in CNS drug development, N-methylpiperidin-3-amine has also been explored for its potential in other therapeutic areas. Studies have indicated its utility in designing molecules that target cardiovascular diseases, where its structural properties contribute to improved efficacy and reduced side effects. The compound's versatility makes it a valuable asset in the pharmaceutical toolkit, offering opportunities for innovation across multiple disease domains.

The synthesis of N-methylpiperidin-3-amine has been optimized through various chemical methodologies, ensuring high yields and purity suitable for industrial-scale production. Advances in synthetic techniques have enabled researchers to access this compound efficiently, facilitating its use in large-scale drug development programs. These improvements have been crucial in reducing costs and accelerating the time-to-market for new pharmaceuticals.

In conclusion, N-methylpiperidin-3-amine (CAS No. 150395-92-9) represents a cornerstone molecule in modern pharmaceutical chemistry. Its unique structural properties and versatile applications make it an indispensable tool for drug discovery and development. As research continues to uncover new therapeutic possibilities, this compound is poised to play an even greater role in addressing some of the most pressing challenges in medicine today.

• 22990-77-8(2-Piperidinemethanamine)
• 54012-73-6(piperidin-3-amine)
• 5298-72-6((1-Methylpiperidin-2-yl)methanamine)
• 531-67-9(2-(2-piperidyl)piperidine)
• 80918-66-7((S)-3-Piperidinamine)
• 127294-73-9((R)-Piperidin-3-amine)
• 57734-57-3(2-(Aminomethyl)pyrrolidine)
• 69154-03-6(Azepan-3-amine)
• 50534-49-1(N,N-Dimethylpiperidin-3-amine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)